Geovax to participate in upcoming investor conferences in september

Atlanta, ga, sept. 03, 2024 (globe newswire) -- geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its chairman and ceo, david dodd, will present at two upcoming investor events:
GOVX Ratings Summary
GOVX Quant Ranking